Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Extracellular Vesicles, A Possible Theranostic Platform Strategy for Hepatocellular Carcinoma-An Overview.

D'Agnano I, Berardi AC.

Cancers (Basel). 2020 Jan 21;12(2). pii: E261. doi: 10.3390/cancers12020261. Review.

2.

Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ß1 and miRNA21 cooperation.

Camerlingo R, Miceli R, Marra L, Rea G, D'Agnano I, Nardella M, Montella R, Morabito A, Normanno N, Tirino V, Rocco G.

PLoS One. 2019 Jul 25;14(7):e0219597. doi: 10.1371/journal.pone.0219597. eCollection 2019.

3.

RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines.

Berardocco M, Radeghieri A, Busatto S, Gallorini M, Raggi C, Gissi C, D'Agnano I, Bergese P, Felsani A, Berardi AC.

Oncotarget. 2017 Aug 24;8(47):82920-82939. doi: 10.18632/oncotarget.20503. eCollection 2017 Oct 10.

4.

Lamin A/C Is Required for ChAT-Dependent Neuroblastoma Differentiation.

Guglielmi L, Nardella M, Musa C, Iannetti I, Arisi I, D'Onofrio M, Storti A, Valentini A, Cacci E, Biagioni S, Augusti-Tocco G, D'Agnano I, Felsani A.

Mol Neurobiol. 2017 Jul;54(5):3729-3744. doi: 10.1007/s12035-016-9902-6. Epub 2016 May 25.

PMID:
27221609
5.

Down-regulation of the Lamin A/C in neuroblastoma triggers the expansion of tumor initiating cells.

Nardella M, Guglielmi L, Musa C, Iannetti I, Maresca G, Amendola D, Porru M, Carico E, Sessa G, Camerlingo R, Dominici C, Megiorni F, Milan M, Bearzi C, Rizzi R, Pirozzi G, Leonetti C, Bucci B, Mercanti D, Felsani A, D'Agnano I.

Oncotarget. 2015 Oct 20;6(32):32821-40. doi: 10.18632/oncotarget.5104.

6.

Signaling by exosomal microRNAs in cancer.

Falcone G, Felsani A, D'Agnano I.

J Exp Clin Cancer Res. 2015 Apr 2;34:32. doi: 10.1186/s13046-015-0148-3. Review.

7.

Human placenta-derived neurospheres are susceptible to transformation after extensive in vitro expansion.

Amendola D, Nardella M, Guglielmi L, Cerquetti L, Carico E, Alesi V, Porru M, Leonetti C, Bearzi C, Rizzi R, D'Agnano I, Stigliano A, Novelli G, Bucci B.

Stem Cell Res Ther. 2014 Apr 22;5(2):55. doi: 10.1186/scrt444.

8.

MYCN gene expression is required for the onset of the differentiation programme in neuroblastoma cells.

Guglielmi L, Cinnella C, Nardella M, Maresca G, Valentini A, Mercanti D, Felsani A, D'Agnano I.

Cell Death Dis. 2014 Feb 20;5:e1081. doi: 10.1038/cddis.2014.42.

9.

LMNA knock-down affects differentiation and progression of human neuroblastoma cells.

Maresca G, Natoli M, Nardella M, Arisi I, Trisciuoglio D, Desideri M, Brandi R, D'Aguanno S, Nicotra MR, D'Onofrio M, Urbani A, Natali PG, Del Bufalo D, Felsani A, D'Agnano I.

PLoS One. 2012;7(9):e45513. doi: 10.1371/journal.pone.0045513. Epub 2012 Sep 26.

10.

Good Caco-2 cell culture practices.

Natoli M, Leoni BD, D'Agnano I, Zucco F, Felsani A.

Toxicol In Vitro. 2012 Dec;26(8):1243-6. doi: 10.1016/j.tiv.2012.03.009. Epub 2012 Mar 23.

PMID:
22465559
11.

Differentiation of Caco-2 cells requires both transcriptional and post-translational down-regulation of Myc.

Leoni BD, Natoli M, Nardella M, Bucci B, Zucco F, D'Agnano I, Felsani A.

Differentiation. 2012 Mar;83(3):116-27. doi: 10.1016/j.diff.2011.10.005. Epub 2011 Nov 20.

PMID:
22364879
12.

Shotgun proteomics and network analysis of neuroblastoma cell lines treated with curcumin.

D'Aguanno S, D'Agnano I, De Canio M, Rossi C, Bernardini S, Federici G, Urbani A.

Mol Biosyst. 2012 Apr;8(4):1068-77. doi: 10.1039/c2mb05498a. Epub 2012 Feb 7.

PMID:
22315092
13.

Oxygen sensing is impaired in ATM-defective cells.

Mongiardi MP, Stagni V, Natoli M, Giaccari D, D'Agnano I, Falchetti ML, Barilà D, Levi A.

Cell Cycle. 2011 Dec 15;10(24):4311-20. doi: 10.4161/cc.10.24.18663. Epub 2011 Dec 15.

PMID:
22134239
14.

CPTH6, a thiazole derivative, induces histone hypoacetylation and apoptosis in human leukemia cells.

Trisciuoglio D, Ragazzoni Y, Pelosi A, Desideri M, Carradori S, Gabellini C, Maresca G, Nescatelli R, Secci D, Bolasco A, Bizzarri B, Cavaliere C, D'Agnano I, Filetici P, Ricci-Vitiani L, Rizzo MG, Del Bufalo D.

Clin Cancer Res. 2012 Jan 15;18(2):475-86. doi: 10.1158/1078-0432.CCR-11-0579. Epub 2011 Nov 8.

15.

Ago1 and Ago2 differentially affect cell proliferation, motility and apoptosis when overexpressed in SH-SY5Y neuroblastoma cells.

Parisi C, Giorgi C, Batassa EM, Braccini L, Maresca G, D'agnano I, Caputo V, Salvatore A, Pietrolati F, Cogoni C, Catalanotto C.

FEBS Lett. 2011 Oct 3;585(19):2965-71. doi: 10.1016/j.febslet.2011.08.003. Epub 2011 Aug 11.

16.

Temozolomide induced c-Myc-mediated apoptosis via Akt signalling in MGMT expressing glioblastoma cells.

De Salvo M, Maresca G, D'agnano I, Marchese R, Stigliano A, Gagliassi R, Brunetti E, Raza GH, De Paula U, Bucci B.

Int J Radiat Biol. 2011 May;87(5):518-33. doi: 10.3109/09553002.2011.556173. Epub 2011 Mar 15.

PMID:
21405945
17.

Cell growing density affects the structural and functional properties of Caco-2 differentiated monolayer.

Natoli M, Leoni BD, D'Agnano I, D'Onofrio M, Brandi R, Arisi I, Zucco F, Felsani A.

J Cell Physiol. 2011 Jun;226(6):1531-43. doi: 10.1002/jcp.22487.

PMID:
20945374
18.

Neural stem cells modified to express BDNF antagonize trimethyltin-induced neurotoxicity through PI3K/Akt and MAP kinase pathways.

Casalbore P, Barone I, Felsani A, D'Agnano I, Michetti F, Maira G, Cenciarelli C.

J Cell Physiol. 2010 Sep;224(3):710-21. doi: 10.1002/jcp.22170.

PMID:
20432466
19.

UDP exerts cytostatic and cytotoxic actions in human neuroblastoma SH-SY5Y cells over-expressing P2Y6 receptor.

Apolloni S, Finocchi P, D'Agnano I, Alloisio S, Nobile M, D'Ambrosi N, Volonté C.

Neurochem Int. 2010 Apr;56(5):670-8. doi: 10.1016/j.neuint.2010.02.003. Epub 2010 Feb 6.

PMID:
20144676
20.

MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway.

Mancini F, Di Conza G, Pellegrino M, Rinaldo C, Prodosmo A, Giglio S, D'Agnano I, Florenzano F, Felicioni L, Buttitta F, Marchetti A, Sacchi A, Pontecorvi A, Soddu S, Moretti F.

EMBO J. 2009 Jul 8;28(13):1926-39. doi: 10.1038/emboj.2009.154. Epub 2009 Jun 11.

21.

MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel.

Gatti G, Maresca G, Natoli M, Florenzano F, Nicolin A, Felsani A, D'Agnano I.

PLoS One. 2009;4(5):e5442. doi: 10.1371/journal.pone.0005442. Epub 2009 May 6.

22.

Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts.

Falchetti ML, Mongiardi MP, Fiorenzo P, Petrucci G, Pierconti F, D'Agnano I, D'Alessandris G, Alessandri G, Gelati M, Ricci-Vitiani L, Maira G, Larocca LM, Levi A, Pallini R.

Int J Cancer. 2008 Mar 15;122(6):1236-42.

23.

Oligopeptides impairing the Myc-Max heterodimerization inhibit lung cancer cell proliferation by reducing Myc transcriptional activity.

D'Agnano I, Valentini A, Gatti G, Chersi A, Felsani A.

J Cell Physiol. 2007 Jan;210(1):72-80.

PMID:
16998799
24.

Gemcitabine treatment of experimental C6 glioma: the effects on cell cycle and apoptotic rate.

Carpinelli G, Bucci B, D'Agnano I, Canese R, Caroli F, Raus L, Brunetti E, Giannarelli D, Podo F, Carapella CM.

Anticancer Res. 2006 Jul-Aug;26(4B):3017-24.

25.

c-MYC deregulation is involved in melphalan resistance of multiple myeloma: role of PDGF-BB.

Greco C, D'Agnano I, Vitelli G, Vona R, Marino M, Mottolese M, Zuppi C, Capoluongo E, Ameglio F.

Int J Immunopathol Pharmacol. 2006 Jan-Mar;19(1):67-79.

PMID:
16569345
26.

Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.

Bucci B, D'Agnano I, Amendola D, Citti A, Raza GH, Miceli R, De Paula U, Marchese R, Albini S, Felsani A, Brunetti E, Vecchione A.

Clin Cancer Res. 2005 Apr 1;11(7):2756-67.

27.

In vitro and in vivo tumor growth inhibition by a p16-mimicking peptide in p16INK4A-defective, pRb-positive human melanoma cells.

Noonan DM, Severino A, Morini M, Tritarelli A, Manente L, D'Agnano I, Starace G, Baldi A, Lombardi D, Albini A, Felsani A, Paggi MG.

J Cell Physiol. 2005 Mar;202(3):922-8.

PMID:
15389561
28.

Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt.

Asnaghi L, Calastretti A, Bevilacqua A, D'Agnano I, Gatti G, Canti G, Delia D, Capaccioli S, Nicolin A.

Oncogene. 2004 Jul 29;23(34):5781-91.

PMID:
15208671
29.

MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus.

Peschiaroli A, Figliola R, Coltella L, Strom A, Valentini A, D'Agnano I, Maione R.

Oncogene. 2002 Nov 21;21(53):8114-27. Erratum in: Oncogene. 2003 Mar 20;22(11):1747.

30.

Verapamil reverts resistance to drug-induced apoptosis in Ki-ras-transformed cells by altering the cell membrane and the mitochondrial transmembrane potentials.

Spalletti-Cernia D, D'Agnano I, Sorrentino R, Zupi G, Vecchio G, Portella G, Laccetti P.

Oncol Res. 2002;13(1):25-35.

PMID:
12201671
31.

Biological indicators of aggressiveness in T1 ductal invasive breast cancer.

Bucci B, Carico E, Rinaldi A, Froio F, Puce YM, D'Agnano I, Vecchione A, Brunetti E.

Anticancer Res. 2001 Jul-Aug;21(4B):2949-55.

PMID:
11712792
32.

p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy.

Buglioni S, D'Agnano I, Vasselli S, Perrone Donnorso R, D'Angelo C, Brenna A, Benevolo M, Cosimelli M, Zupi G, Mottolese M.

Am J Clin Pathol. 2001 Sep;116(3):360-8.

PMID:
11554164
33.

Myc down-regulation induces apoptosis in M14 melanoma cells by increasing p27(kip1) levels.

D'Agnano I, Valentini A, Fornari C, Bucci B, Starace G, Felsani A, Citro G.

Oncogene. 2001 May 17;20(22):2814-25.

34.

c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings.

Biroccio A, Benassi B, D'Agnano I, D'Angelo C, Buglioni S, Mottolese M, Ricciotti A, Citro G, Cosimelli M, Ramsay RG, Calabretta B, Zupi G.

Am J Pathol. 2001 Apr;158(4):1289-99.

35.

Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription.

Guardavaccaro D, Corrente G, Covone F, Micheli L, D'Agnano I, Starace G, Caruso M, Tirone F.

Mol Cell Biol. 2000 Mar;20(5):1797-815.

36.

Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.

Buglioni S, D'Agnano I, Cosimelli M, Vasselli S, D'Angelo C, Tedesco M, Zupi G, Mottolese M.

Int J Cancer. 1999 Dec 22;84(6):545-52.

37.

Effects of poly(ADP-ribose) polymerase inhibition on cell death and chromosome damage induced by VP16 and bleomycin.

D'Agnano I, Antonelli A, Bucci B, Marcucci L, Petrinelli P, Ambra R, Zupi G, Elli R.

Environ Mol Mutagen. 1998;32(1):56-63.

PMID:
9707099
38.

The role of multiploidy as unfavorable prognostic variable in colorectal cancer.

Cosimelli M, D'Agnano I, Tedesco M, D'Angelo C, Botti C, Giannarelli D, Vasselli S, Cavaliere F, Zupi G, Cavaliere R.

Anticancer Res. 1998 May-Jun;18(3B):1957-65.

PMID:
9677450
39.

c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.

Citro G, D'Agnano I, Leonetti C, Perini R, Bucci B, Zon G, Calabretta B, Zupi G.

Cancer Res. 1998 Jan 15;58(2):283-9.

40.

DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis.

Santoro E, Carboni M, Catarci M, Carlini M, Carboni F, Zupi G, Vecchione A, D'Agnano I, Giannarelli D, Santoro R, Garofalo A.

Hepatogastroenterology. 1997 May-Jun;44(15):826-37.

PMID:
9222700
41.

EGF-R expression in ductal breast cancer: proliferation and prognostic implications.

Bucci B, D'Agnano I, Botti C, Mottolese M, Carico E, Zupi G, Vecchione A.

Anticancer Res. 1997 Jan-Feb;17(1B):769-74.

PMID:
9066618
42.

nm23 influences proliferation and differentiation of PC12 cells in response to nerve growth factor.

Gervasi F, D'Agnano I, Vossio S, Zupi G, Sacchi A, Lombardi D.

Cell Growth Differ. 1996 Dec;7(12):1689-95.

43.

Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.

Del Bufalo D, Cucco C, Leonetti C, Citro G, D'Agnano I, Benassi M, Geiser T, Zon G, Calabretta B, Zupi G.

Br J Cancer. 1996 Aug;74(3):387-93.

44.

DNA ploidy, cell kinetics, and epidermal growth factor receptor and HER2/neu oncoprotein expression in primary operable breast cancer.

d'Agnano I, Bucci B, Mottolese M, Benevolo M, Conti L, Botti C, Vecchione A, Casillo S, Zupi G.

Ann N Y Acad Sci. 1996 Apr 30;784:472-81. No abstract available.

PMID:
8651601
45.

Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.

Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro G C, Zupi G.

J Natl Cancer Inst. 1996 Apr 3;88(7):419-29.

PMID:
8618233
46.

Adriamycin resistance modulation induced by lonidamine in human breast cancer cells.

Zupi G, Molinari A, D'Agnano I, Meschini S, Del Bufalo D, Matarrese P, Candiloro A, Calcabrini A, Citro G, Arancia G.

Anticancer Res. 1995 Nov-Dec;15(6B):2469-77.

PMID:
8669810
47.

DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.

D'Agnano I, D'Angelo C, Savarese A, Carlini M, Garofalo A, Bottari L, Santoro E, Giannarelli D, Vecchione A, Zupi G.

Lab Invest. 1995 Apr;72(4):432-8.

PMID:
7723282
48.

Gastric cancer cell DNA content correlates with early and late results after gastrectomy.

Carlini M, Garofalo A, Rinaldi G, D'Agnano I, D'Angelo C, Zupi G, Vecchione A, Santoro E.

Int Surg. 1994 Apr-Jun;79(2):114-9.

PMID:
7928145
49.

Biologic and clinical correlations among ploidy, cell kinetics, and the tumor-associated glycoprotein-72 tissue expression in colorectal cancer. Preliminary findings.

Cavaliere F, Guadagni F, D'Agnano I, Casaldi V, Sciarretta F, Spila A, Cosimelli M.

Dis Colon Rectum. 1994 Feb;37(2 Suppl):S24-9.

PMID:
8313788
50.

N-methylformamide as a potential therapeutic approach in colon cancer.

Del Bufalo D, Bucci B, D'Agnano I, Zupi G.

Dis Colon Rectum. 1994 Feb;37(2 Suppl):S133-7.

PMID:
8313785

Supplemental Content

Loading ...
Support Center